Cargando…
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
Introduction: In the last decade, healthcare for the transgender population has increased considerably in many countries thanks to depathologization movements and the easier accessibility of medical assistance. The age at which they request to start gender-affirming hormones (GAHs) is increasingly y...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573211/ https://www.ncbi.nlm.nih.gov/pubmed/37834785 http://dx.doi.org/10.3390/jcm12196141 |